TESTBANK
,Table of Contents
l l
Chapter l01: lThe lNursing lProcess land lDrug lTherapy ................................................................................. 4
Chapter l02: lPharmacologic lPrinciples....................................................................................................... 8
Chapter l03: lLifespan lConsiderations ...................................................................................................... 14
Chapter l04: lCultural, lLegal, land lEthical lConsiderations .......................................................................... 20
Chapter l05: lMedication lErrors: lPreventing land lResponding ................................................................... 26
Chapter l06: lPatient lEducation land lDrug lTherapy ................................................................................... 29
Chapter l07: lOver-the-Counter lDrugs land lHerbal land lDietary lSupplements ............................................ 34
Chapter l08: lGene lTherapy land lPharmacogenomics ............................................................................... 38
Chapter l09: lPhoto lAtlas lof lDrug lAdministration..................................................................................... 41
Chapter l10: lAnalgesic lDrugs................................................................................................................... 50
Chapter l11: lGeneral land lLocal lAnesthetics ............................................................................................ 57
Chapter l12: lCentral lNervous lSystem lDepressants land lMuscle lRelaxants ................................................ 61
Chapter l13: lCentral lNervous lSystem lStimulants land lRelated lDrugs ....................................................... 66
Chapter l14: lAntiepileptic lDrugs.............................................................................................................. 70
Chapter l15: lAntiparkinson lDrugs ............................................................................................................ 76
Chapter l16: lPsychotherapeutic lDrugs..................................................................................................... 81
Chapter l17: lSubstance lUse lDisorder ...................................................................................................... 88
Chapter l18: lAdrenergic lDrugs ................................................................................................................ 93
Chapter l19: lAdrenergic-Blocking lDrugs .................................................................................................. 98
Chapter l20: lCholinergic lDrugs.............................................................................................................. 103
Chapter l21: lCholinergic-Blocking lDrugs ................................................................................................ 108
Chapter l22: lAntihypertensive lDrugs ..................................................................................................... 113
Chapter l23: lAntianginal lDrugs.............................................................................................................. 119
Chapter l24: lHeart lFailure lDrugs ........................................................................................................... 125
Chapter l25: lAntidysrhythmic lDrugs...................................................................................................... 131
Chapter l26: lCoagulation lModifier lDrugs .............................................................................................. 137
Chapter l27: lAntilipemic lDrugs.............................................................................................................. 143
Chapter l28: lDiuretic lDrugs ................................................................................................................... 148
Chapter l29: lFluids land lElectrolytes ...................................................................................................... 154
Chapter l30: lPituitary lDrugs .................................................................................................................. 160
,Chapter l31: lThyroid land lAntithyroid lDrugs .......................................................................................... 163
Chapter l32: lAntidiabetic lDrugs ............................................................................................................. 168
Chapter l33: lAdrenal lDrugs ................................................................................................................... 177
Chapter l34: lWomen’s lHealth lDrugs ..................................................................................................... 181
Chapter l35: lMen’s lHealth lDrugs .......................................................................................................... 188
Chapter l36: lAntihistamines, lDecongestants, lAntitussives, land lExpectorants......................................... 193
Chapter l37: lRespiratory lDrugs ............................................................................................................. 198
Chapter l38: lAntibiotics lPart l1............................................................................................................... 204
Chapter l39: lAntibiotics lPart l2............................................................................................................... 211
Chapter l40: lAntiviral lDrugs .................................................................................................................. 216
Chapter l41: lAntitubercular lDrugs ......................................................................................................... 221
Chapter l42: lAntifungal lDrugs ............................................................................................................... 226
Chapter l43: lAntimalarial, lAntiprotozoal, land lAnthelmintic lDrugs ......................................................... 231
Chapter l44: lAnti-inflammatory land lAntigout lDrugs.............................................................................. 236
Chapter l45: lAntineoplastic lDrugs lPart l1: lCancer lOverview land lCell lCycle–Specific lDrugs...................... 242
Chapter l46: lAntineoplastic lDrugs lPart l2: lCell lCycle–Nonspecific lDrugs land lMiscellaneous lDrugs .......... 248
Chapter l47: lBiologic lResponse–Modifying land lAntirheumatic lDrugs..................................................... 253
Chapter l48: lImmunosuppressant lDrugs ............................................................................................... 258
Chapter l49: lImmunizing lDrugs ............................................................................................................. 263
Chapter l50: lAcid-Controlling lDrugs ...................................................................................................... 268
Chapter l51: lBowel lDisorder lDrugs ....................................................................................................... 274
Chapter l52: lAntiemetic land lAntinausea lDrugs ..................................................................................... 281
Chapter l53: lVitamins land lMinerals ...................................................................................................... 286
Chapter l54: lAnemia lDrugs ................................................................................................................... 292
Chapter l55: lNutritional lSupplements ................................................................................................... 299
Chapter l56: lDermatologic lDrugs........................................................................................................... 304
Chapter l57: lOphthalmic lDrugs ............................................................................................................. 310
Chapter l58: lOtic lDrugs ......................................................................................................................... 315
, Chapter l01: lThe lNursing lProcess land lDrug lTherapy l l l 4
Chapter 01: The Nursing Process and Drug Therapy
l l l l l l l
MULTIPLE lCHOICE
1. The lnurse lis lwriting la lnursing ldiagnosis lfor la lplan lof lcare lfor la lpatient lwho lhas lbeen
newly ldiagnosed lwith ltype l2 ldiabetes. lWhich lstatement lreflects lthe lcorrect lformat lfor la
l
nursing ldiagnosis?
l
a. Anxiety
b. Anxiety lrelated lto lnew ldrug ltherapy
c. Anxietylrelated lto lanxious lfeelings labout ldrug ltherapy, las levidenced lby
lstatements lsuch las l“I’m lupset labout lhaving lto ltest lmy lblood lsugars.”
d. Anxietylrelated lto lnew ldrug ltherapy, las levidenced lby lstatements lsuch las
l“I’m lupset labout lhaving lto ltest lmy lblood l sugars.”
ANS: l D
Formulation lof lnursing ldiagnoses lis lusually la lthree-step lprocess. l“Anxiety” lis lmissing lthe
l“related lto” land l“as levidenced lby” lportions lof ldefining lcharacteristics. l“Anxiety lrelated lto
lnew ldrug ltherapy” lis lmissing lthe l“as levidenced lby” lportion lof ldefining lcharacteristics. lThe
lstatement lbeginning l“Anxiety lrelated lto lanxious l feelings” lis lincorrect lbecause lthe l“related lto”
lsection lis l simply la lrestatement lof lthe lproblem l“anxiety,” lnot la lseparate lfactor lrelated lto lthe
lresponse.
DIF: COGNITIVE lLEVEL: lUnderstanding l(Comprehension)
lTOP: l NURSING lPROCESS: lNursing lDiagnosis
MSC: l NCLEX: lSafe land lEffective lCare lEnvironment: lManagement lof lCare
2. The lpatient lis lto lreceive loral lguaifenesin l(Mucinex) ltwice la lday. lToday, lthe lnurse lwas lbusy
land lgave lthe lmedication l2 lhours lafter lthe lscheduled ldose lwas ldue. lWhat ltype lof lproblem
ldoes lthis lrepresent?
a. “Right ltime”
b. “Right ldose”
c. “Right lroute”
d. “Right lmedication”
ANS: l A
“Right ltime” lis lcorrect lbecause lthe lmedication lwas lgiven lmore lthan l30 lminutes lafter lthe
lscheduled ldose lwas ldue. l“Dose” lis lincorrect lbecause lthe ldose lis lnot lrelated lto lthe ltime lthe
lmedication ladministration lis lscheduled. l“Route” lis lincorrect lbecause lthe lroute lis lnot laffected.
l“Medication” lis lincorrect lbecause lthe lmedication lordered lwill lnot lchange.
DIF: COGNITIVE lLEVEL: lApplying l(Application)
lTOP: l NURSING lPROCESS: lImplementation
MSC: l NCLEX: lSafe land lEffective lCare lEnvironment: lSafety land lInfection lControl
3. The lnurse lhas lbeen lmonitoring lthe lpatient’s lprogress lon la lnew ldrug lregimen lsince lthe lfirst
ldose land ldocumenting lthe lpatient’s ltherapeutic lresponse lto lthe lmedication. lWhich lphase lof
lthe lnursing lprocess ldo lthese lactions lillustrate?
a. Nursing ldiagnosis
,Table of Contents
l l
Chapter l01: lThe lNursing lProcess land lDrug lTherapy ................................................................................. 4
Chapter l02: lPharmacologic lPrinciples....................................................................................................... 8
Chapter l03: lLifespan lConsiderations ...................................................................................................... 14
Chapter l04: lCultural, lLegal, land lEthical lConsiderations .......................................................................... 20
Chapter l05: lMedication lErrors: lPreventing land lResponding ................................................................... 26
Chapter l06: lPatient lEducation land lDrug lTherapy ................................................................................... 29
Chapter l07: lOver-the-Counter lDrugs land lHerbal land lDietary lSupplements ............................................ 34
Chapter l08: lGene lTherapy land lPharmacogenomics ............................................................................... 38
Chapter l09: lPhoto lAtlas lof lDrug lAdministration..................................................................................... 41
Chapter l10: lAnalgesic lDrugs................................................................................................................... 50
Chapter l11: lGeneral land lLocal lAnesthetics ............................................................................................ 57
Chapter l12: lCentral lNervous lSystem lDepressants land lMuscle lRelaxants ................................................ 61
Chapter l13: lCentral lNervous lSystem lStimulants land lRelated lDrugs ....................................................... 66
Chapter l14: lAntiepileptic lDrugs.............................................................................................................. 70
Chapter l15: lAntiparkinson lDrugs ............................................................................................................ 76
Chapter l16: lPsychotherapeutic lDrugs..................................................................................................... 81
Chapter l17: lSubstance lUse lDisorder ...................................................................................................... 88
Chapter l18: lAdrenergic lDrugs ................................................................................................................ 93
Chapter l19: lAdrenergic-Blocking lDrugs .................................................................................................. 98
Chapter l20: lCholinergic lDrugs.............................................................................................................. 103
Chapter l21: lCholinergic-Blocking lDrugs ................................................................................................ 108
Chapter l22: lAntihypertensive lDrugs ..................................................................................................... 113
Chapter l23: lAntianginal lDrugs.............................................................................................................. 119
Chapter l24: lHeart lFailure lDrugs ........................................................................................................... 125
Chapter l25: lAntidysrhythmic lDrugs...................................................................................................... 131
Chapter l26: lCoagulation lModifier lDrugs .............................................................................................. 137
Chapter l27: lAntilipemic lDrugs.............................................................................................................. 143
Chapter l28: lDiuretic lDrugs ................................................................................................................... 148
Chapter l29: lFluids land lElectrolytes ...................................................................................................... 154
Chapter l30: lPituitary lDrugs .................................................................................................................. 160
,Chapter l31: lThyroid land lAntithyroid lDrugs .......................................................................................... 163
Chapter l32: lAntidiabetic lDrugs ............................................................................................................. 168
Chapter l33: lAdrenal lDrugs ................................................................................................................... 177
Chapter l34: lWomen’s lHealth lDrugs ..................................................................................................... 181
Chapter l35: lMen’s lHealth lDrugs .......................................................................................................... 188
Chapter l36: lAntihistamines, lDecongestants, lAntitussives, land lExpectorants......................................... 193
Chapter l37: lRespiratory lDrugs ............................................................................................................. 198
Chapter l38: lAntibiotics lPart l1............................................................................................................... 204
Chapter l39: lAntibiotics lPart l2............................................................................................................... 211
Chapter l40: lAntiviral lDrugs .................................................................................................................. 216
Chapter l41: lAntitubercular lDrugs ......................................................................................................... 221
Chapter l42: lAntifungal lDrugs ............................................................................................................... 226
Chapter l43: lAntimalarial, lAntiprotozoal, land lAnthelmintic lDrugs ......................................................... 231
Chapter l44: lAnti-inflammatory land lAntigout lDrugs.............................................................................. 236
Chapter l45: lAntineoplastic lDrugs lPart l1: lCancer lOverview land lCell lCycle–Specific lDrugs...................... 242
Chapter l46: lAntineoplastic lDrugs lPart l2: lCell lCycle–Nonspecific lDrugs land lMiscellaneous lDrugs .......... 248
Chapter l47: lBiologic lResponse–Modifying land lAntirheumatic lDrugs..................................................... 253
Chapter l48: lImmunosuppressant lDrugs ............................................................................................... 258
Chapter l49: lImmunizing lDrugs ............................................................................................................. 263
Chapter l50: lAcid-Controlling lDrugs ...................................................................................................... 268
Chapter l51: lBowel lDisorder lDrugs ....................................................................................................... 274
Chapter l52: lAntiemetic land lAntinausea lDrugs ..................................................................................... 281
Chapter l53: lVitamins land lMinerals ...................................................................................................... 286
Chapter l54: lAnemia lDrugs ................................................................................................................... 292
Chapter l55: lNutritional lSupplements ................................................................................................... 299
Chapter l56: lDermatologic lDrugs........................................................................................................... 304
Chapter l57: lOphthalmic lDrugs ............................................................................................................. 310
Chapter l58: lOtic lDrugs ......................................................................................................................... 315
, Chapter l01: lThe lNursing lProcess land lDrug lTherapy l l l 4
Chapter 01: The Nursing Process and Drug Therapy
l l l l l l l
MULTIPLE lCHOICE
1. The lnurse lis lwriting la lnursing ldiagnosis lfor la lplan lof lcare lfor la lpatient lwho lhas lbeen
newly ldiagnosed lwith ltype l2 ldiabetes. lWhich lstatement lreflects lthe lcorrect lformat lfor la
l
nursing ldiagnosis?
l
a. Anxiety
b. Anxiety lrelated lto lnew ldrug ltherapy
c. Anxietylrelated lto lanxious lfeelings labout ldrug ltherapy, las levidenced lby
lstatements lsuch las l“I’m lupset labout lhaving lto ltest lmy lblood lsugars.”
d. Anxietylrelated lto lnew ldrug ltherapy, las levidenced lby lstatements lsuch las
l“I’m lupset labout lhaving lto ltest lmy lblood l sugars.”
ANS: l D
Formulation lof lnursing ldiagnoses lis lusually la lthree-step lprocess. l“Anxiety” lis lmissing lthe
l“related lto” land l“as levidenced lby” lportions lof ldefining lcharacteristics. l“Anxiety lrelated lto
lnew ldrug ltherapy” lis lmissing lthe l“as levidenced lby” lportion lof ldefining lcharacteristics. lThe
lstatement lbeginning l“Anxiety lrelated lto lanxious l feelings” lis lincorrect lbecause lthe l“related lto”
lsection lis l simply la lrestatement lof lthe lproblem l“anxiety,” lnot la lseparate lfactor lrelated lto lthe
lresponse.
DIF: COGNITIVE lLEVEL: lUnderstanding l(Comprehension)
lTOP: l NURSING lPROCESS: lNursing lDiagnosis
MSC: l NCLEX: lSafe land lEffective lCare lEnvironment: lManagement lof lCare
2. The lpatient lis lto lreceive loral lguaifenesin l(Mucinex) ltwice la lday. lToday, lthe lnurse lwas lbusy
land lgave lthe lmedication l2 lhours lafter lthe lscheduled ldose lwas ldue. lWhat ltype lof lproblem
ldoes lthis lrepresent?
a. “Right ltime”
b. “Right ldose”
c. “Right lroute”
d. “Right lmedication”
ANS: l A
“Right ltime” lis lcorrect lbecause lthe lmedication lwas lgiven lmore lthan l30 lminutes lafter lthe
lscheduled ldose lwas ldue. l“Dose” lis lincorrect lbecause lthe ldose lis lnot lrelated lto lthe ltime lthe
lmedication ladministration lis lscheduled. l“Route” lis lincorrect lbecause lthe lroute lis lnot laffected.
l“Medication” lis lincorrect lbecause lthe lmedication lordered lwill lnot lchange.
DIF: COGNITIVE lLEVEL: lApplying l(Application)
lTOP: l NURSING lPROCESS: lImplementation
MSC: l NCLEX: lSafe land lEffective lCare lEnvironment: lSafety land lInfection lControl
3. The lnurse lhas lbeen lmonitoring lthe lpatient’s lprogress lon la lnew ldrug lregimen lsince lthe lfirst
ldose land ldocumenting lthe lpatient’s ltherapeutic lresponse lto lthe lmedication. lWhich lphase lof
lthe lnursing lprocess ldo lthese lactions lillustrate?
a. Nursing ldiagnosis
